UMB Revenue Rises 13.9% to $772.4 Million in Third Quarter
Key Facts
UMB Financial reported revenue of $772.4 million in the third quarter of 2026, up 13.9% from the same period last year, according to a company filing with the U.S. Securities and Exchange Commission. Net interest margin on a tax-equivalent basis was 3.32%, up 28 basis points year over year. Results showed growth in lending and deposits alongside improved asset-quality indicators. The company also recorded a return on average assets of 1.53% and a return on average common equity of 13.83%. UMB Financial shares closed at $133.8 on October 27, according to EL7 data.
Average loans rose to $41.7 billion, up 11.1% year over year calculated from the prior quarter, according to the company filing. Total loan production was $3.1 billion in the third quarter, compared with $2.6 billion in the second quarter. Chief Executive Mariner Kemper said total loan production reached a record $3.1 billion. He added that net loan growth, after repayments and paydowns, was $1.4 billion during the quarter. The figures reflect an expansion in lending, while portfolio performance remains an important complement to the growth picture.
Average deposits were $58.2 billion, up 4.4% year over year calculated from the prior quarter. On a direct year-over-year comparison, the average increased by $1.5 billion, or 2.6%, from the third quarter of 2025, the company said. The ratio of nonperforming loans to total loans improved to 28 basis points on September 30, from 31 basis points on June 30, 2026. Net loan charge-offs totaled $14 million during the quarter, equivalent to 13 basis points of average loans. Kemper said asset-quality metrics remained strong, alongside growth in fee income and a stable net interest margin.
The efficiency ratio under generally accepted accounting principles improved to 48.71% in the third quarter, from 58.09% in the year-earlier quarter, according to the filing. The ratio measures expenses relative to revenue, and its improvement coincided with higher company revenue. Management pointed to factors that could weigh on the business environment, including persistent inflation, conflict in the Middle East, and higher short- and long-term interest rates. Kemper said customer sentiment and demand for commercial investment remained strong across the markets and business lines in which the company operates. His comments presented a picture of potential economic risks alongside continued demand, without changing the company’s stated guidance for the next quarter.
For the fourth quarter, management expects the core net interest margin to remain relatively stable compared with the 3.10% recorded in the third quarter. It also expects the effective tax rate to range between 21% and 22% in the fourth quarter, according to the earnings-call transcript. The guidance indicates management’s assumptions for the coming period as it monitors the effects of interest rates and inflation on banking activity. Chesapeake Utilities shares, for which the available evidence here does not include confirmed third-quarter results, closed at $134.63 on October 27, according to EL7 data. In its second-quarter results, the company reported net income of $25.4 million and earnings per share of $1.05, while year-to-date net income was $84.7 million and earnings per share was $3.51.
On Chesapeake Utilities’ investments, the company reported capital expenditures of $139.7 million in the second quarter of 2026 and $261.6 million year to date. It also said the Florida Public Service Commission approved annual interim rates of $16.2 million, effective in July 2026, as part of the Florida City Gas rate case. The company also announced the proposed Florida Energy Pathway, a $1.2 billion natural gas pipeline in South Florida. The project’s contracted capacity is about 250,000 therms per day, and it is targeted to begin operations in 2030. These projects and investments provide context for the company’s operations ahead of its subsequent results, without confirming an announcement date for those results in the available evidence.